Clinical Trials Directory

Trials / Completed

CompletedNCT02331992

Positive Airway Pressure Program

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Fisher and Paykel Healthcare · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Obstructive Sleep Apnea (OSA) is a common sleep disordered breathing condition effecting around 2-4% of the middle aged population and is characterized by periodic collapse of the upper airway during sleep. Continuous Positive Airway Pressure (CPAP) is the primary treatment for patients with OSA. Despite the effectiveness of CPAP in abolishing upper airway obstruction, acceptance of and adherence with therapy has been sub-optimal. Over the past decade, considerable research has focused on determining the factors responsible for poor CPAP adherence. Two key areas have been identified: patient-reported symptoms, including mask discomfort, pressure intolerance and nasal symptoms and the importance of patient education and support. In addition we know that the patient experience during the crucial first days and weeks of their journey predicts longer term adherence. This study investigates the ability of an automated program that assists patients towards continuous positive airway pressure (CPAP) therapy adherence.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAdherence programParticipants will receive supportive messages while enrolled in the program.

Timeline

Start date
2015-02-01
Primary completion
2015-07-01
Completion
2015-09-01
First posted
2015-01-06
Last updated
2018-10-29
Results posted
2018-10-29

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02331992. Inclusion in this directory is not an endorsement.

Positive Airway Pressure Program (NCT02331992) · Clinical Trials Directory